未找到相关数据
Phase II trial of clinical activity and safety of ceritinib combined with stereotactic ablative radiotherapy (SABR) in lung adenocarcinoma patients.
被引：0
|作者：
Khan, Saad A.
Gerber, David E.
Zhu, Hong
Hughes, Randall S.
Mannala, Samantha
Rashdan, Sawsan
Dowell, Jonathan
Westover, Kenneth D.
Saltarski, Jessica
Harrah, Kasia
Priddy, Laurin
Choy, Hak
Timmerman, Robert D.
Brekken, Rolf A.
Sorrelle, Noah
Iyengar, Puneeth
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Texas Southwestern, Irving, TX USA
[3] Univ Texas Southwestern Med Ctr, Ft Worth, TX USA
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21571
引用
收藏
页数：2
相关论文